|
Volumn 31, Issue 10, 2009, Pages 746-851
|
[Combination with SN-38 on human colon cancer LoVo cells].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAMPTOTHECIN;
DRUG DERIVATIVE;
HIF1A PROTEIN, HUMAN;
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
IRINOTECAN;
MESSENGER RNA;
MITOGEN ACTIVATED PROTEIN KINASE;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
ARTICLE;
CELL HYPOXIA;
CELL PROLIFERATION;
COLON TUMOR;
DRUG EFFECT;
DRUG POTENTIATION;
GENETICS;
HUMAN;
METABOLISM;
PATHOLOGY;
SIGNAL TRANSDUCTION;
TIME;
TUMOR CELL LINE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
CELL HYPOXIA;
CELL LINE, TUMOR;
CELL PROLIFERATION;
COLONIC NEOPLASMS;
DRUG SYNERGISM;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
HUMANS;
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;
RNA, MESSENGER;
SIGNAL TRANSDUCTION;
TIME FACTORS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 79952116544
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|